[HTML][HTML] A novel machine learning 13-gene signature: Improving risk analysis and survival prediction for clear cell renal cell carcinoma patients
P Terrematte, DS Andrade, J Justino, B Stransky… - Cancers, 2022 - mdpi.com
Simple Summary Clear cell renal cell carcinoma is a type of kidney cancer which comprises
the majority of all renal cell carcinomas. Many efforts have been made to identify biomarkers …
the majority of all renal cell carcinomas. Many efforts have been made to identify biomarkers …
A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients.
P Terrematte, DS Andrade, J Justino, B Stransky… - …, 2022 - search.ebscohost.com
Abstract Simple Summary: Clear cell renal cell carcinoma is a type of kidney cancer which
comprises the majority of all renal cell carcinomas. Many efforts have been made to identify …
comprises the majority of all renal cell carcinomas. Many efforts have been made to identify …
[HTML][HTML] A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients
P Terrematte, DS Andrade, J Justino, B Stransky… - Cancers, 2022 - ncbi.nlm.nih.gov
Patients with clear cell renal cell carcinoma (ccRCC) have poor survival outcomes,
especially if it has metastasized. It is of paramount importance to identify biomarkers in …
especially if it has metastasized. It is of paramount importance to identify biomarkers in …
A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients.
P Terrematte, DS Andrade, J Justino, B Stransky… - Cancers, 2022 - europepmc.org
Patients with clear cell renal cell carcinoma (ccRCC) have poor survival outcomes,
especially if it has metastasized. It is of paramount importance to identify biomarkers in …
especially if it has metastasized. It is of paramount importance to identify biomarkers in …
[PDF][PDF] A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients. Cancers 2022 …
P Terrematte, DS Andrade, J Justino, B Stransky… - 2022 - academia.edu
Patients with clear cell renal cell carcinoma (ccRCC) have poor survival outcomes,
especially if it has metastasized. It is of paramount importance to identify biomarkers in …
especially if it has metastasized. It is of paramount importance to identify biomarkers in …
A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients
P Terrematte, DS Andrade, J Justino, B Stransky… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Patients with clear cell renal cell carcinoma (ccRCC) have poor survival outcomes,
especially if it has metastasized. It is of paramount importance to identify biomarkers in …
especially if it has metastasized. It is of paramount importance to identify biomarkers in …
A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients
P Terrematte, DS Andrade, J Justino, B Stransky… - …, 2022 - search.proquest.com
Patients with clear cell renal cell carcinoma (ccRCC) have poor survival outcomes,
especially if it has metastasized. It is of paramount importance to identify biomarkers in …
especially if it has metastasized. It is of paramount importance to identify biomarkers in …
[PDF][PDF] A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients. Cancers 2022 …
P Terrematte, DS Andrade, J Justino, B Stransky… - 2022 - researchgate.net
Patients with clear cell renal cell carcinoma (ccRCC) have poor survival outcomes,
especially if it has metastasized. It is of paramount importance to identify biomarkers in …
especially if it has metastasized. It is of paramount importance to identify biomarkers in …